재고 위치

New Jersey, USA
Czech Republic, EU
Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

384329-76-4Abacavir-5'-glucuronide

● Under Development

카탈로그 번호:	VL760019
CAS 번호:	384329-76-4
분자식:	C20H26N6O7
분자량:	462.47 g/mol

무엇을 도와드

RFQ 목록에 추가

에 대한 추가 정보 CAS 384329-76-4

모약물

Abacavir

IUPAC명

(2S, 3S, 4S, 5R)-6-((4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methoxy)-3, 4, 5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid

약전 동의어

N/A

Other Synonyms

Abacavir 5′-beta-D-Glucuronide; Abacavir glucuronide; abacavir glucosiduronic acid; Abacavir 5′-glucosiduronic acid; ABACAVIR 5′-B-D-GLUCURONIDE; (2S,3S,4S,5R,6R)-6-[[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid; ((1S,4R)-4-(2-Amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopenten-1-yl)methyl beta-D-glucopyranosiduronic acid beta-D-Glucopyranosiduronic acid; ((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopenten-1-yl)methyl; {(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methyl beta-D-glucopyranosiduronic acid; ((1S,4R)-4-(2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL)-2-CYCLOPENTEN-1-YL)METHYL .BETA.-D-GLUCOPYRANOSIDURONIC ACID; (2S,3S,4S,5R,6R)-6-(((1S,4R)-4-(2-Amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid

설명

Abacavir-5'-glucuronide (CAS No: 384329-76-4) is one of the major metabolites of Abacavir which is a nucleoside analog, HIV-1 reverse transcriptase inhibitor, and a potent in vivo and in vitro inhibitor of HIV-1 that causes acquired immunodeficiency syndrome.

References

Ravitch, Joshua R., and Caroline G. Moseley. “High-Performance Liquid Chromatographic Assay for Abacavir and Its Two Major Metabolites in Human Urine and Cerebrospinal Fluid.” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 762, no. 2, Oct. 2001, pp. 165–73, https://doi.org/10.1016/s0378-4347(01)00361-9.